People

Connected nebulizer maker AireHealth has announced the appointment of Kien Nguyen as its new CEO and as a member of its board. Nguyen was most recently Chief Commercial Officer at Progenerative Medical. In December 2020, AireHealth announced that it had received 510(k) clearance for its VitalMed connected portable vibrating mesh nebulizer. AireHealth Kien … [Read more...] about AireHealth names Kien Nguyen as CEO

Impel NeuroPharma has named Leonard S. Paolillo as Chief Commercial Officer and Gerald F. Penn as VP, Market Access and Trade in anticipation of the launch of Trudhesa intranasal dihydroergotamine mesylate (DHE) for the treatment of migraine headaches if approved by the FDA. Impel submitted an NDA for Trudhesa (INP104)in November 2020, and the FDA has set a PDUFA goal … [Read more...] about Impel NeuroPharma announces management appointments to support potential launch of its Trudhesa intranasal DHE

Dutch DPI developer PureIMS has announced the appointment of Bram van Dijck as its new Chief Executive Officer, succeeding Reinier Schwietert, who is stepping down as CEO but will remain with the company. Van Dijck was most recently Global Head Portfolio Management at the Grünenthal Group and has worked in executive positions at numerous pharmaceutical companies, … [Read more...] about PureIMS names Bram van Dijck as CEO

According to Proveris Scientific, Lynn Jordan has joined the company as Applications Laboratory Manager. Proveris offers laboratory services for development and analysis of a wide range of OINDPs, and the company launched new cGMP compliant testing services earlier this year. Jordan was most recently a Technical Sales Representative with Biotage and has held … [Read more...] about Proveris Scientific announces new hire for Applications Laboratory Manager

Inhalation CDMO Vectura has announced the resignation of Aerami CEO Anne Whitaker from Vectura's board of directors "in light of potential conflicts that could arise in the future as a result of her role of Chief Executive Officer at Aerami Therapeutics." In June 2020, Vectura and Aerami announced a partnership agreement for development of inhaled imatinib (VR325) … [Read more...] about Aerami CEO Anne Whitaker steps down from Vectura board of directors

Inhaled drug developer Savara has announced the departures of its co-founders, CEO Rob Neville and President and Chief Business Officer Taneli Jouhikainen, who have resigned "to pursue other opportunities," according to the company. Matthew Pauls, who has been a member of the company's board of directors since Mast's 2017 merger with Savara, will step in as interim … [Read more...] about Savara announces resignations of CEO and President

Finnish nanonization specialist Nanoform has announced the appointments of Eric Peter and Sergie Letser to the company’s US business development team. In January 2020, Nanoform announced the appointment of Sally Langa as its new Head of US Sales, and in February, the company announced that it had established a US subsidiary. Langa has since left the company. Peter … [Read more...] about Nanoform appoints US business development executives

Inhaled drug company MannKind Corporation has announced the appointment of Kevin Kaiserman as VP, Medical Affairs and Safety. Kaiserman, a pedicatric endocrinologist, was most recently in private practice. The company markets Afrezza inhaled insulin, which was approved by the FDA in 2014, and is partnered with United Therapeutics on development of a treprostinil … [Read more...] about MannKind appoints Kevin Kaiserman as VP, Medical Affairs and Safety

Aerosol testing company Proveris Scientific has announced two new appointments: Joseph Werbeck rejoins the company as Senior Director of Technical Service and Mohamed Eldam joins Proveris as Applications Chemist. Werbeck, who will report to VP of Technical Service Alberto Correia, served as Director of Technical Service at Proveris from 2014-2018 before leaving for a … [Read more...] about Proveris Scientific announces two appointments